Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Clinical trial NCT05361668 · COMPLETED

Trial details

NCT number: NCT05361668
Sponsor: Crinetics Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoid Syndrome Carcinoid Carcinoid Tumor Carcinoid Tumor of Ileum Carcinoid Tumor of Cecum Carcinoid Syndrome Diarrhea Carcinoid Intestine Tumor Carcinoid Tumor of Liver Carcinoid Tumor of Pancreas

Start date: 2022-04-22
Primary completion: 2024-03-07
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.